189 related articles for article (PubMed ID: 34164940)
1. Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.
Musangile FY; Matsuzaki I; Okodo M; Shirasaki A; Mikasa Y; Iwamoto R; Takahashi Y; Kojima F; Murata SI
Cancer Med; 2021 Aug; 10(16):5534-5544. PubMed ID: 34164940
[TBL] [Abstract][Full Text] [Related]
2. p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma.
Alexander RE; Hu Y; Kum JB; Montironi R; Lopez-Beltran A; Maclennan GT; Idrees MT; Emerson RE; Ulbright TM; Grignon DG; Eble JN; Cheng L
Mod Pathol; 2012 Nov; 25(11):1526-33. PubMed ID: 22684221
[TBL] [Abstract][Full Text] [Related]
3. Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation.
Kim SH; Joung JY; Chung J; Park WS; Lee KH; Seo HK
PLoS One; 2014; 9(3):e93525. PubMed ID: 24675970
[TBL] [Abstract][Full Text] [Related]
4. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients.
Ben Selma W; Ziadi S; Ben Gacem R; Amara K; Ksiaa F; Hachana M; Trimeche M
Pathol Res Pract; 2010 Nov; 206(11):740-3. PubMed ID: 20674191
[TBL] [Abstract][Full Text] [Related]
5. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
6. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV.
Gordetsky J; Spieker AJ; Pena MDCR; Kamanda S; Anderson MR; Cheville J; Boorjian S; Frank I; Granada CP; Comperat E; Hirsch MS; Iczkowski KA; Imblum B; Schwartz L; Giannico GA; Rais-Bahrami S
Urology; 2020 Oct; 144():158-163. PubMed ID: 32681917
[TBL] [Abstract][Full Text] [Related]
7. Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.
Blochin EB; Park KJ; Tickoo SK; Reuter VE; Al-Ahmadie H
Mod Pathol; 2012 Nov; 25(11):1534-42. PubMed ID: 22766788
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.
De Gaetani C; Ferrari G; Righi E; Bettelli S; Migaldi M; Ferrari P; Trentini GP
J Clin Pathol; 1999 Feb; 52(2):103-6. PubMed ID: 10396236
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization.
López-Beltrán A; Escudero AL; Carrasco-Aznar JC; Vicioso-Recio L
Pathol Res Pract; 1996 Feb; 192(2):154-9. PubMed ID: 8692716
[TBL] [Abstract][Full Text] [Related]
10. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
[TBL] [Abstract][Full Text] [Related]
11. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues.
Lu J; Zhao M; Wu C; Chu C; Zhang CZ; Cao Y
Diagn Pathol; 2022 Jan; 17(1):10. PubMed ID: 35027056
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
13. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder.
Collins K; Hwang M; Hamza A; Rao P
Pathol Res Pract; 2020 Sep; 216(9):153084. PubMed ID: 32825952
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas.
Lu QL; Lalani el-N ; Abel P
Eur Urol; 1997; 31(4):428-32. PubMed ID: 9187902
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization.
Lopez-Beltran A; Muñoz E
Histopathology; 1995 Jun; 26(6):565-9. PubMed ID: 7665148
[TBL] [Abstract][Full Text] [Related]
17. Role of human papillomavirus in the development of urothelial carcinoma.
Yavuzer D; Karadayi N; Salepci T; Baloglu H; Bilici A; Sakirahmet D
Med Oncol; 2011 Sep; 28(3):919-23. PubMed ID: 20428971
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction.
Tekin MI; Tuncer S; Aki FT; Bilen CY; Aygün C; Ozen H
Int J Urol; 1999 Apr; 6(4):184-6. PubMed ID: 10226835
[TBL] [Abstract][Full Text] [Related]
19. Loss of Cell Differentiation in HPV-Associated Bladder Cancer.
Golovina DA; Ermilova VD; Zavalishina LE; Andreeva YY; Matveev VB; Frank GA; Volgareva GM
Bull Exp Biol Med; 2016 May; 161(1):96-8. PubMed ID: 27265130
[TBL] [Abstract][Full Text] [Related]
20. Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder.
Abdollahzadeh P; Madani SH; Khazaei S; Sajadimajd S; Izadi B; Najafi F
Urol J; 2017 Nov; 14(6):5047-5050. PubMed ID: 29101759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]